Khavinson VK, Linkova NS, Chalisova NI, Ivko OM
Mehta A, Mason P, Vulliamy T
Diabetes Care 37 , 21592167 (2014)
Besides, this work was also beneficial to the design of newer anti-AD combination therapies
99.276% purity (HPLC) Third-party tested Freedom Diagnostics Identity confirmed Certificate of Analysis Tested by Freedom Diagnostics 03/23/2026 Tested by Janoshik 11/10/2025 Key Ingredients A stable pentadecapeptide (15 amino acids) studied in relation to cytoprotective mechanisms, nitric oxide system interactions, growth factor expression, and angiogenic pathways
C-Terminal Amidation (-NH2) C-terminal amidation helps protect the peptide from carboxypeptidase-mediated degradation, increasing overall molecular stability